Dmitri V. Lissin
Chief Tech/Sci/R&D Officer at SCILEX HOLDING COMPANY
Profile
Dmitri V.
Lissin is currently the Director & Chief Medical Officer at Semnur Pharmaceuticals, Inc. He is also the Chief Medical Officer & Senior Vice President at Scilex, Inc. and Scilex Holding Co. Previously, he served as the Vice President-Clinical Development at XenoPort, Inc. from 2011 to 2015.
Dr. Lissin holds a doctorate degree from the Russian National Research Medical University.
Dmitri V. Lissin active positions
| Companies | Position | Start |
|---|---|---|
| SCILEX HOLDING COMPANY | Chief Tech/Sci/R&D Officer | - |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | 2015-06-30 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Chief Tech/Sci/R&D Officer | 2019-02-28 |
Former positions of Dmitri V. Lissin
| Companies | Position | End |
|---|---|---|
| XENOPORT, INC. | Chief Tech/Sci/R&D Officer | 2015-07-31 |
Training of Dmitri V. Lissin
| Russian National Research Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Private companies | 3 |
|---|---|
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Dmitri V. Lissin
